ClinicalTrials.gg
RecruitingNCT07332299ReSTARTUpdated Jan 12, 2026

Remote Stimulation and Training to Advance Recovery From TBI in Seniors

An interventional study of Active tDCS and Cognitive Training Intervention and Sham tDCS and Cognitive Training Intervention in Traumatic Brain Injury and Aging Related Cognitive Decline, sponsored by Minneapolis Veterans Affairs Medical Center. Recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-01-12.

Sponsored by Minneapolis Veterans Affairs Medical Center · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 909 studies in Brain Injuries, Traumatic with a site in United States — 212 open to participants now, 250 under way, 5 of them phase 3. Brain Injuries, Traumatic · United States.

Planned enrollment
366th of 650
40 · median 50
Started
2026
with 64 others
No phase
441 of 909
111 open now
Primary completion
2027-09
later than 139 of 249 live
Registered
841st of 909
by date

Among the 909 studies in Brain Injuries, Traumatic with a site in United States, this one is the 366th largest by planned enrollment of the 650 interventional ones that give a count, is one of 65 that started in 2026, is one of 441 with no phase, reaches primary completion later than 139 of the 249 other live ones, and was the 841st registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

212 of the 909 studies in Brain Injuries, Traumatic with a site in United States are open now. Recruiting first, the newest first:

207 more — sign in →

All 212 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 909 studies in Brain Injuries, Traumatic with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if combining brain stimulation with cognitive training can improve thinking skills in older adults who have had a traumatic brain injury (TBI).

The main questions are:

  • Does transcranial direct current stimulation (tDCS) make cognitive training more effective for improving attention, memory, and decision-making?
  • Is this type of home-based program feasible and acceptable for older adults with TBI?

Researchers will compare two groups: one group will receive active tDCS during cognitive training, and the other group will receive sham (placebo) tDCS during cognitive training.

Participants will:

  • Complete computer-based cognitive training exercises (BrainHQ) to practice attention, memory, and decision-making.
  • Receive either active or sham tDCS during training sessions.
  • Complete assessments before and after the program to measure changes in thinking and daily functioning.
Read the detailed description

Traumatic brain injury (TBI) is a major public health issue among older adults. Each year, thousands of seniors sustain TBIs, most often from falls. Even when the injury is classified as "mild," it can lead to long-term problems with memory, attention, decision-making, and self-control. These difficulties can make it harder to live independently, maintain social relationships, and manage everyday responsibilities. Older adults with a history of TBI are also at greater risk of experiencing faster cognitive decline as they age. Unfortunately, there are few effective treatments available to improve thinking skills in this group.

This study is designed to test a new approach that combines **computer-based cognitive training** with **transcranial direct current stimulation (tDCS)**, a safe, non-invasive form of brain stimulation. The goal is to determine whether this combined treatment can improve attention, memory, and decision-making in older adults with TBI, and whether the program is practical for participants to complete at home with remote supervision.

About the Interventions

  • Cognitive training (BrainHQ): Participants will complete computerized exercises that provide structured practice in skills such as attention, working memory, and decision-making. These exercises adapt to each individual's performance, gradually increasing in difficulty as skills improve.
  • tDCS: During some of the training sessions, participants will wear a device with electrodes placed on the scalp. The device delivers a very low level of electrical current (2 milliamps) that helps "tune" brain networks to make them more responsive to training. tDCS is non-invasive, painless for most people, and has been tested safely in thousands of participants in research studies worldwide.

Study Design

This is a randomized controlled trial. All participants will complete the same set of cognitive training exercises, but they will be randomly assigned to one of two groups:

  • Active group: Receives active tDCS during training.
  • Sham group: Receives sham (placebo) tDCS during training. Sham stimulation mimics the feeling of tDCS at the start of the session but does not deliver active current.

This design allows researchers to determine whether adding tDCS produces greater improvements than cognitive training alone.

Study Procedures

Participants will:

  1. Complete baseline assessments of cognitive function, daily living skills, and quality of life.
  2. Take part in multiple sessions of computer-based cognitive training at home, while supervised remotely through secure telehealth connections.
  3. Receive either active or sham tDCS during the training sessions.
  4. Complete follow-up assessments after the intervention to measure changes in thinking, decision-making, and daily functioning.

Key Questions

The study is designed to answer three main questions:

  1. Does tDCS enhance the effects of cognitive training? Specifically, do participants who receive active tDCS show greater gains in attention, memory, and decision-making compared to those who receive sham stimulation?
  2. Is the program feasible and acceptable? Can older adults with TBI successfully complete the home-based training and stimulation sessions, and do they find the program easy to use and worthwhile?
  3. Do improvements transfer to everyday life? Beyond test scores, does the program help participants function better in their daily lives, maintain independence, and improve quality of life?

Importance of the Study

Older adults with TBI are at particularly high risk for poor outcomes, but they are often underrepresented in research. This study is innovative in several ways:

  • It focuses specifically on older adults with TBI, a group that has historically been overlooked in clinical trials.
  • It uses a home-based and remotely supervised model, which increases accessibility for people living in rural areas, those with mobility limitations, or those who cannot easily attend clinic visits.
  • It builds on strong preliminary evidence from prior studies in Veterans and other populations showing that combining brain stimulation with cognitive training can reduce impulsivity and improve cognitive control.
  • It addresses a critical gap in treatment by testing a scalable rehabilitation approach that could be delivered widely if proven effective.

Potential Impact

If successful, this research could provide the foundation for a new, effective treatment option for older adults with TBI. The intervention is low-risk, non-invasive, and can be delivered in the home setting with minimal equipment. It could help participants improve cognitive functioning, maintain independence longer, and enhance quality of life. At a broader level, the study could reduce the burden of TBI-related cognitive decline on families, caregivers, and healthcare systems.

03

Conditions studied

  • Traumatic Brain Injury
  • Aging Related Cognitive Decline

Keywords

  • Aging
  • Cognitive Training
  • Transcranial Direct Current Stimulation
  • Traumatic Brain Injury
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Veterans age 65 and older.
  2. History of mild TBI (as defined by the DOD/VA criteria used in conjunction with the OSU TBI-ID) sustained at least 3 months prior to enrollment.
  3. Self-reported or medically documented attention and/or concentration difficulties.
  4. Stable dose of all prescription and non-prescription medications that may impact cognition or brain chemistry (except for PRN medication) for at least 3 weeks prior to the baseline session (Visit 1), in the medical opinion of the principal investigator.
  5. Capable and willing to provide voluntary , in the medical opinion of the principal investigator.

Exclusion criteria

Exclusion Criteria:

  1. Presence of a medical, psychiatric, physical or non-physical disease, disorder, condition, injury, disability or pre-existent history such that study participation, in the opinion of the principal investigator: (a) may pose a significant risk to the participant, (b) raises the possibility that the participant is unlikely to successfully complete all the requirements of the study according to the study protocol, or (c) might adversely impact the integrity of the data or the validity of the study results. Specific conditions include (but are not limited to) a history of brain tumor near the stimulation site, brain surgery, stroke with current sequalae, epilepsy, multiple sclerosis, Huntington's Disease, ALS, ataxia, aphasia, Alzheimer's Disease, and dementia.
  2. Moderate to severe cognitive impairment with score (assessed upon enrollment) less than 15.
  3. Prior treatment with ECT or neuromodulation in the last 12 months.
  4. Current severe alcohol or substance use disorder with evidence of withdrawal or tolerance within the past 6 months, based on psychiatric history and/or a review of available medical records.
  5. Psychosis or mania within 30 days of enrollment, as determined by the principal investigator, based on psychiatric history and/or a review of available medical records.
  6. for tDCS (e.g., metallic cranial plates/screws or implanted device, eczema or skin lesions on scalp near electrode site, etc.).
  7. No or limited internet connection in their home.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Active tDCS with cognitive training

    Participants will receive 10 sessions of cognitive training concurrent with transcranial direct current stimulation (45 minutes of cognitive training with tDCS applied for first 20 minutes of session; tDCS: 2mA, 30s ramp up/down, anode at F3, cathode at F4).

    Combination Product: Active tDCS and Cognitive Training Intervention

  • Sham comparator
    Sham tDCS with cognitive training

    Participants will receive 10 sessions of cognitive training concurrent with sham transcranial direct current stimulation (45 minutes of cognitive training with sham tDCS: 2mA current will be ramped down immediately after the initial 30s ramp up period and then at 20 minutes ramped up and down as done at the beginning, anode at F3, cathode at F4).

    Combination Product: Sham tDCS and Cognitive Training Intervention

Interventions

  • Combination productActive tDCS and Cognitive Training Intervention

    Forty-five minutes of cognitive training concurrent with 2 mAmps of anodal stimulation applied to the left frontal cortex for the first 20 minutes of the session.

    Also known as: tDCS

  • Combination productSham tDCS and Cognitive Training Intervention

    Forty-five minutes of cognitive training concurrent with sham tDCS (30 secs ramp up/ramp down of current at beginning and end of session).

    Also known as: sham tDCS

06

What researchers measure

Primary outcomes

  1. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Total Scale Score

    The RBANS is a commonly-used, psychometrically-sound measure of cognitive function across the lifespan. The primary outcome measure is the Total Scale score, which is a standard score (mean 100, SD 15) across five cognitive domains (Immediate/Delayed Memory, Visuospatial, Attention, Language).

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

  2. Electroencephalogram (EEG) - Resting State Theta Band Functional Connectivity

    Resting State EEG will be collected to assess neural dynamics or functional connectivity and spectral power of delta,theta, alpha, beta, and gamma frequency bands. The primary outcome measure will be change in prefrontal-parietal functional connectivity in the theta frequency band.

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

Secondary outcomes

  1. Neurobehavioral Symptom Inventory (NSI) Total Score

    A 22-item measure that assesses post-concussive symptoms for those with a TBI.

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

  2. Insomnia Severity Index (ISI) Total Score

    A 7-item measure of the severity of nighttime and daytime components of insomnia.

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

  3. Patient Health Questionnaire-8 (PHQ-8) Total Score

    An 8-item measure of depressive symptoms.

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

  4. Groton Maze Learning Task (GMLT) Completion Time

    A computer cognitive test of spatial working memory and error monitoring.

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

  5. NIH Toolbox Quality of Life Assessment (NeuroQoL)

    Questionnaire to assess quality of life with regard to cognitive, social, emotional, and behavioral abilities.

    Time frame: Baseline, 1-week post, & 6-weeks post intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Sep 2027, 20 months later.

Of 445 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 20 months is below that.

Counting every sponsor, half of 467 studies reached it within 41 months; a quarter within 22 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2025
First posted
Jan 12, 2026
StartEst.
Jan 15, 2026
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Jan 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07332299
Lead sponsor
Minneapolis Veterans Affairs Medical Center
Collaborators
Center for Veterans Research and Education
Responsible party
Casey Gilmore, PhD (Principal Investigator, Minneapolis Veterans Affairs Medical Center) — Principal investigator
First posted
Jan 12, 2026
Start date
Jan 15, 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Jan 12, 2026

Study contacts

Casey S Gilmore, PhD
Contact
casey.gilmore2@va.gov
612-629-7466
Laura Hemmy, PhD
Contact
laura.hemmy@va.gov
612-467-2323

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion